Home › Diffuse Intrinsic Pontine Glioma › Alabama › Birmingham
Diffuse Intrinsic Pontine Glioma clinical trials in Birmingham, AL
3 studies for Diffuse Intrinsic Pontine Glioma are looking for participants at sites in and around Birmingham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
RecruitingPhase 1/2
- Children's Hospital of Alabama, Birmingham
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
RecruitingPhase 1/2
- University of Alabama/Children's of Alabama, Birmingham
Combination Therapy for the Treatment of Diffuse Midline Gliomas
RecruitingPhase 2
- University of Alabama at Birmingham, Birmingham
Diffuse Intrinsic Pontine Glioma trials in other cities
- Washington, DC11 studies
- Seattle, WA10 studies
- Philadelphia, PA10 studies
- Columbus, OH10 studies
- Cincinnati, OH10 studies
- Houston, TX10 studies
- Chicago, IL9 studies
- Durham, NC9 studies
- Boston, MA9 studies
- Aurora, CO8 studies
- Miami, FL6 studies
- Ann Arbor, MI6 studies
Other studies in Birmingham
- Cancer (all types)31 studies
- Breast Cancer24 studies
- Ovarian Cancer23 studies
- Obesity23 studies
- Non-Small Cell Lung Cancer22 studies
- Acute Myeloid Leukemia21 studies
- Multiple Myeloma18 studies
- COPD17 studies
- Cardiovascular Disease17 studies
- Type 2 Diabetes16 studies
- Endometrial Cancer16 studies
- Overweight16 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.